Ada W.Y. Leung

865 total citations
30 papers, 720 citations indexed

About

Ada W.Y. Leung is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Ada W.Y. Leung has authored 30 papers receiving a total of 720 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 11 papers in Oncology and 8 papers in Biomaterials. Recurrent topics in Ada W.Y. Leung's work include Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Metal complexes synthesis and properties (4 papers). Ada W.Y. Leung is often cited by papers focused on Nanoparticle-Based Drug Delivery (8 papers), RNA Interference and Gene Delivery (7 papers) and Metal complexes synthesis and properties (4 papers). Ada W.Y. Leung collaborates with scholars based in Canada, Sweden and Netherlands. Ada W.Y. Leung's co-authors include Marcel B. Bally, Mohamed Wehbe, Malathi Anantha, Chris Orvig, Michael J. Abrams, Roger Gilabert‐Oriol, Ian Backstrom, Wieslawa H. Dragowska, Gemma M. Ryan and Katarina Edwards and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Ada W.Y. Leung

29 papers receiving 710 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ada W.Y. Leung Canada	17	300	275	174	137	95	30	720
Mohamed Wehbe Canada	17	337 1.1×	231 0.8×	130 0.7×	173 1.3×	183 1.9×	26	746
Bernhard Englinger Austria	14	304 1.0×	273 1.0×	166 1.0×	61 0.4×	79 0.8×	28	699
Shanhe Li China	18	270 0.9×	350 1.3×	179 1.0×	143 1.0×	172 1.8×	37	766
Carmen A. Widmer Switzerland	3	318 1.1×	320 1.2×	127 0.7×	95 0.7×	122 1.3×	3	698
Kushtrim Kryeziu Austria	15	344 1.1×	412 1.5×	185 1.1×	62 0.5×	61 0.6×	25	846
Michael Weinmüller Germany	11	509 1.7×	201 0.7×	179 1.0×	127 0.9×	118 1.2×	13	884
Yunlong Lu China	17	263 0.9×	426 1.5×	377 2.2×	59 0.4×	100 1.1×	29	954
Ye Wu China	17	692 2.3×	268 1.0×	167 1.0×	87 0.6×	126 1.3×	54	1.2k
Dongfan Song China	18	390 1.3×	353 1.3×	193 1.1×	91 0.7×	221 2.3×	32	910

Countries citing papers authored by Ada W.Y. Leung

Since Specialization

Citations

This map shows the geographic impact of Ada W.Y. Leung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ada W.Y. Leung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ada W.Y. Leung more than expected).

Fields of papers citing papers by Ada W.Y. Leung

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ada W.Y. Leung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ada W.Y. Leung. The network helps show where Ada W.Y. Leung may publish in the future.

Co-authorship network of co-authors of Ada W.Y. Leung

This figure shows the co-authorship network connecting the top 25 collaborators of Ada W.Y. Leung. A scholar is included among the top collaborators of Ada W.Y. Leung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ada W.Y. Leung. Ada W.Y. Leung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sharifiaghdam, Maryam, et al.. (2025). Liposomal Formulations of Metal-CX5461 complexes: Copper-CX5461 complexation mediates CX5461 degradation while Zinc-CX5461 formulations are suitable for development. Journal of Drug Delivery Science and Technology. 114. 107586–107586. 1 indexed citations

Chiu, K.W., Ada W.Y. Leung, Ka Yu Tse, et al.. (2025). CT-based radiomics model to predict platinum sensitivity in epithelial ovarian carcinoma: a multicentre study. Cancer Imaging. 25(1). 85–85. 1 indexed citations

Leung, Ada W.Y., Roger Gilabert‐Oriol, Jayesh A. Kulkarni, et al.. (2025). Liposomal delivery of a disulfiram metabolite drives copper-mediated tumor immunity. International Journal of Pharmaceutics. 683. 126010–126010.

Dragowska, Wieslawa H., Jagbir Singh, Mohamed Wehbe, et al.. (2024). Liposomal Formulation of Hydroxychloroquine Can Inhibit Autophagy In Vivo. Pharmaceutics. 17(1). 42–42. 2 indexed citations

Anantha, Malathi, et al.. (2021). Development and characterization of a novel flavopiridol formulation for treatment of acute myeloid leukemia. Journal of Controlled Release. 333. 246–257. 21 indexed citations

Toumazis, Iakovos, Oğuzhan Alagöz, Ada W.Y. Leung, & Sylvia K. Plevritis. (2019). P2.11-02 Individualized Risk-Based Lung Cancer Screening Incorporating Past Screening Findings and Changes in Smoking Behaviors. Journal of Thoracic Oncology. 14(10). S792–S792. 2 indexed citations

Anantha, Malathi, Ada W.Y. Leung, Jayesh A. Kulkarni, et al.. (2019). Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use. Drug Delivery and Translational Research. 10(1). 202–215. 29 indexed citations

Leung, Ada W.Y., Malathi Anantha, Wieslawa H. Dragowska, Mohamed Wehbe, & Marcel B. Bally. (2018). Copper-CX-5461: A novel liposomal formulation for a small molecule rRNA synthesis inhibitor. Journal of Controlled Release. 286. 1–9. 19 indexed citations

Gilabert‐Oriol, Roger, et al.. (2018). Liposomal Formulations to Modulate the Tumour Microenvironment and Antitumour Immune Response. International Journal of Molecular Sciences. 19(10). 2922–2922. 38 indexed citations

10.

Prosser, Kathleen E., et al.. (2018). Transition Metal Ions Promote the Bioavailability of Hydrophobic Therapeutics: Cu and Zn Interactions with RNA Polymerase I Inhibitor CX5461. Chemistry - A European Journal. 24(24). 6334–6338. 7 indexed citations

11.

Leung, Ada W.Y., Chansey J. Veinotte, Min Hee Oh, et al.. (2017). In Vivo Validation of PAPSS1 (3′-phosphoadenosine 5′-phosphosulfate synthase 1) as a Cisplatin-sensitizing Therapeutic Target. Clinical Cancer Research. 23(21). 6555–6566. 9 indexed citations

12.

Wehbe, Mohamed, Malathi Anantha, Minghan Shi, et al.. (2017). Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent. International Journal of Nanomedicine. Volume 12. 4129–4146. 58 indexed citations

13.

Wehbe, Mohamed, Cody Lo, Ada W.Y. Leung, et al.. (2017). Copper (II) complexes of bidentate ligands exhibit potent anti-cancer activity regardless of platinum sensitivity status. Investigational New Drugs. 35(6). 682–690. 31 indexed citations

14.

Wehbe, Mohamed, Malathi Anantha, Ada W.Y. Leung, et al.. (2017). A simple passive equilibration method for loading carboplatin into pre-formed liposomes incubated with ethanol as a temperature dependent permeability enhancer. Journal of Controlled Release. 252. 50–61. 38 indexed citations

15.

Wehbe, Mohamed, Malathi Anantha, Ian Backstrom, et al.. (2016). Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development. PLoS ONE. 11(4). e0153416–e0153416. 46 indexed citations

16.

Leung, Ada W.Y., Stacy Hung, Ian Backstrom, et al.. (2016). Combined Use of Gene Expression Modeling and siRNA Screening Identifies Genes and Pathways Which Enhance the Activity of Cisplatin When Added at No Effect Levels to Non-Small Cell Lung Cancer Cells In Vitro. PLoS ONE. 11(3). e0150675–e0150675. 12 indexed citations

17.

Leung, Ada W.Y., Chansey J. Veinotte, Ian Backstrom, et al.. (2016). Abstract 3792: PAPSS1 (3’-phosphoadenosine 5’-phosphosulfate synthase 1) inhibition sensitizes non-small cell lung cancer to cisplatin treatment in vivo. Cancer Research. 76(14_Supplement). 3792–3792. 1 indexed citations

18.

Leung, Ada W.Y., Jessica Kalra, Nancy Dos Santos, Marcel B. Bally, & Michael S. Anglesio. (2014). Harnessing The Potential of Lipid-Based Nanomedicines for Type-Specific Ovarian Cancer Treatments. Nanomedicine. 9(3). 501–522. 10 indexed citations

19.

Semple, Sean C., Adam D. Judge, Marjorie Robbins, et al.. (2011). Abstract 2829: Preclinical characterization of TKM-080301, a lipid nanoparticle formulation of a small interfering RNA directed against polo-like kinase 1. Cancer Research. 71(8_Supplement). 2829–2829. 17 indexed citations

20.

Pless, Stephan A., Ada W.Y. Leung, Jason D. Galpin, & Christopher A. Ahern. (2011). Contributions of Conserved Residues at the Gating Interface of Glycine Receptors. Journal of Biological Chemistry. 286(40). 35129–35136. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact